LEHIGH VALLEY TOXICOLOGY LLC NPI 1265846695

NPI Details

LEHIGH VALLEY TOXICOLOGY LLC is a clinical medical laboratory in Bethlehem, PA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. LEHIGH VALLEY TOXICOLOGY LLC NPI is 1265846695. The provider is registered as an organization entity type.

The provider's business location address is:

2550 BRODHEAD RD STE 202
BETHLEHEM, PA
ZIP 18020-922
Phone: (267) 566-2075
Fax: (215) 253-4110

The provider's authorized official is Lisa Jackson .
The authorized official title is President and has the following contact phone number (267) 566-2075.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants (HCPCS:81291)
• Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
• Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Genomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes (HCPCS:81443)
• Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (adenomatous polyposis coli), full gene sequence (HCPCS:81201)
• Test for detecting genes for disorders related to ashkenazi jews, genomic sequence analysis panel, at least 9 genes (HCPCS:81412)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Molecular pathology procedure level 4 (HCPCS:81403)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Molecular pathology procedure level 2 (HCPCS:81401)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants (HCPCS:81227)
• Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant (HCPCS:81328)
• Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis (HCPCS:81192)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Test for detecting genes associated with inherited disease of heart muscle (HCPCS:81439)
• Gene analysis (noonan syndrome) genomic sequence analysis (HCPCS:81442)
• Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants (HCPCS:81162)
• Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
• Gene analysis (neurotrophic receptor tyrosine kinase 1, 2, and 3) translocation analysis (HCPCS:81194)
• Gene analysis (glucosidase, beta, acid) common variants (HCPCS:81251)

The enumeration date for this NPI number is 6/13/2014 and was last updated on 5/15/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.